Yasheng Zhu - Search Results

Year	Number of Results
2014	1
2015	5
2016	3
2017	4
2018	4
2019	8
2020	5
2021	8
2022	8
2023	8
2024	1

1

Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression.

Chen S, Zhu G, Yang Y, Wang F, Xiao YT, Zhang N, Bian X, Zhu Y, Yu Y, Liu F, Dong K, Mariscal J, Liu Y, Soares F, Loo Yau H, Zhang B, Chen W, Wang C, Chen D, Guo Q, Yi Z, Liu M, Fraser M, De Carvalho DD, Boutros PC, Di Vizio D, Jiang Z, van der Kwast T, Berlin A, Wu S, Wang J, He HH, Ren S. Chen S, et al. Among authors: zhu y. Nat Cell Biol. 2021 Jan;23(1):87-98. doi: 10.1038/s41556-020-00613-6. Epub 2021 Jan 8. Nat Cell Biol. 2021. PMID: 33420488

2

Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.

Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira NT, Tan Y, Ci Y, Wu F, Dai X, Guo J, Huang YH, Fan C, Ren S, Sun Y, Freeman GJ, Sicinski P, Wei W. Zhang J, et al. Among authors: zhu y. Nature. 2018 Jan 4;553(7686):91-95. doi: 10.1038/nature25015. Epub 2017 Nov 16. Nature. 2018. PMID: 29160310 Free PMC article.

3

SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.

Jiang Q, Zheng N, Bu L, Zhang X, Zhang X, Wu Y, Su Y, Wang L, Zhang X, Ren S, Dai X, Wu D, Xie W, Wei W, Zhu Y, Guo J. Jiang Q, et al. Among authors: zhu y. Mol Cancer. 2021 Aug 5;20(1):100. doi: 10.1186/s12943-021-01397-5. Mol Cancer. 2021. PMID: 34353330 Free PMC article.

4

Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy.

Peng S, Hu P, Xiao YT, Lu W, Guo D, Hu S, Xie J, Wang M, Yu W, Yang J, Chen H, Zhang X, Zhu Y, Wang Y, Yang Y, Zhu G, Chen S, Wang J, Zhang B, Chen W, Wu H, Sun Z, Ding T, Zhang H, Yi Z, Liu M, Ren S. Peng S, et al. Among authors: zhu y. Clin Cancer Res. 2022 Feb 1;28(3):552-567. doi: 10.1158/1078-0432.CCR-21-0299. Epub 2021 Nov 5. Clin Cancer Res. 2022. PMID: 34740924

5

Discovery of Novel Fourth-Generation EGFR Inhibitors to Overcome C797S-Mediated Resistance.

Zhu Y, Ye X, Shen H, Li J, Cai Z, Min W, Hou Y, Dong H, Wu Y, Wang L, Wang X, Xiao Y, Yang P. Zhu Y, et al. J Med Chem. 2023 Nov 9;66(21):14633-14652. doi: 10.1021/acs.jmedchem.3c01165. Epub 2023 Oct 27. J Med Chem. 2023. PMID: 37885208

6

Robotic-assisted versus laparoscopic radical prostatectomy for prostate cancer: the first separate systematic review and meta-analysis of randomised controlled trials and non-randomised studies.

Ma J, Xu W, Chen R, Zhu Y, Wang Y, Cao W, Ju G, Ren J, Ye X, He Q, Chang Y, Ren S. Ma J, et al. Among authors: zhu y. Int J Surg. 2023 May 1;109(5):1350-1359. doi: 10.1097/JS9.0000000000000193. Int J Surg. 2023. PMID: 37070788 Free PMC article.

7

Discovery of Potent and Wild-Type-Sparing Fourth-Generation EGFR Inhibitors for Treatment of Osimertinib-Resistance NSCLC.

Dong H, Ye X, Zhu Y, Shen H, Shen H, Chen W, Ji M, Zheng M, Wang K, Cai Z, Sun H, Xiao Y, Yang P. Dong H, et al. Among authors: zhu y. J Med Chem. 2023 May 25;66(10):6849-6868. doi: 10.1021/acs.jmedchem.3c00277. Epub 2023 May 4. J Med Chem. 2023. PMID: 37141440

8

ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression.

Fan Y, Hou T, Dan W, Zhu Y, Liu B, Wei Y, Wang Z, Gao Y, Zeng J, Li L. Fan Y, et al. Among authors: zhu y. Cell Death Differ. 2022 Aug;29(8):1611-1624. doi: 10.1038/s41418-022-00951-y. Epub 2022 Feb 22. Cell Death Differ. 2022. PMID: 35194188 Free PMC article.

9

E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies.

Wang M, Zhang Z, Li Z, Zhu Y, Xu C. Wang M, et al. Among authors: zhu y. Front Immunol. 2023 Jul 11;14:1226057. doi: 10.3389/fimmu.2023.1226057. eCollection 2023. Front Immunol. 2023. PMID: 37497216 Free PMC article. Review.

10

Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma.

Tang W, Shi Z, Zhu Y, Shan Z, Jiang A, Wang A, Chen M, Bao Y, Ju G, Xu W, Wang J. Tang W, et al. Among authors: zhu y. Sci Rep. 2023 Jul 19;13(1):11668. doi: 10.1038/s41598-023-38914-z. Sci Rep. 2023. PMID: 37468683 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

44 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year